|
1
|
DeSantis C, Siegel R, Bandi P and Jemal A:
Breast cancer statistics, 2011. CA Cancer J Clin. 61:409–418. 2011.
View Article : Google Scholar
|
|
2
|
Tao MH, Shields PG, Nie J, et al: DNA
hypermethylation and clinicopathological features in breast cancer:
the Western New York Exposures and Breast Cancer (WEB) Study.
Breast Cancer Res Treat. 114:559–568. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Holst CR, Nuovo GJ, Esteller M, et al:
Methylation of p16(INK4a) promoters occurs in vivo in
histologically normal human mammary epithelia. Cancer Res.
63:1596–1601. 2003.PubMed/NCBI
|
|
4
|
Tlsty TD, Crawford YG, Holst CR, et al:
Genetic and epigenetic changes in mammary epithelial cells may
mimic early events in carcinogenesis. J Mammary Gland Biol
Neoplasia. 9:263–274. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wajed SA, Laird PW and DeMeester TR: DNA
methylation: An alternative pathway to cancer. Annals Surg.
234:10–20. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baylin SB and Herman JG: DNA
hypermethylation in tumorigenesis - epigenetics joins genetics.
Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esteller M, Corn PG, Baylin SB and Herman
JG: A gene hypermethylation profile of human cancer. Cancer Res.
61:3225–3229. 2001.PubMed/NCBI
|
|
8
|
Di Vinci A, Perdelli L, Banelli B, et al:
p16(INK4a) promoter methylation and protein expression in breast
fibroadenoma and carcinoma. Int J Cancer. 114:414–421.
2005.PubMed/NCBI
|
|
9
|
Lehmann U, Langer F, Feist H, Glockner S,
Hasemeier B and Kreipe H: Quantitative assessment of promoter
hypermethylation during breast cancer development. Am J Pathol.
160:605–612. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cavusoglu AC, Sevinc AI, Saydam S, et al:
Promoter methylation and expression changes of CDH1 and P16 genes
in invasive breast cancer and adjacent normal breast tissue.
Neoplasma. 57:465–472. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jing F, Jun L, Yong Z, et al: Multigene
methylation in serum of sporadic Chinese female breast cancer
patients as a prognostic biomarker. Oncology. 75:60–66. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jing F, Yuping W, Yong C, et al: CpG
island methylator phenotype of multigene in serum of sporadic
breast carcinoma. Tumour Biol. 31:321–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Raish M, Dhillon VS, Ahmad A, et al:
Promoter hypermethylation in tumor suppressing genes p16 and FHIT
and their relationship with estrogen receptor and progesterone
receptor status in breast cancer patients from Northern India.
Transl Oncol. 2:264–270. 2009. View Article : Google Scholar
|
|
14
|
Vallian S, Sedaghat M, Nassiri I and
Frazmand A: Methylation status of p16 (INK4A) tumor suppressor gene
in Iranian patients with sporadic breast cancer. J Cancer Res Clin
Oncol. 135:991–996. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Van Zee KJ, Calvano JE and Bisogna M:
Hypomethylation and increased gene expression of p16(INK4a) in
primary and metastatic breast carcinoma as compared to normal
breast tissue. Oncogene. 16:2723–2727. 1998.PubMed/NCBI
|
|
16
|
Woodcock DM, Linsenmeyer ME, Doherty JP
and Warren WD: DNA methylation in the promoter region of the p16
(CDKN2/MTS-1/INK4A) gene in human breast tumours. Br J Cancer.
79:251–256. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moher D, Liberati A, Tetzlaff J, Altman DG
and Grp P: Preferred reporting items for systematic reviews and
meta-analyses: The PRISMA statement (Reprinted from Annals of
Internal Medicine). Physical Therapy. 89:873–880. 2009.
|
|
18
|
Bero L and Rennie D: The Cochrane
Collaboration. Preparing, maintaining, and disseminating systematic
reviews of the effects of health-care. JAMA. 274:1935–1938. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Higgins JPT, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jing F, Zhang J, Tao J, et al:
Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3
sigma in serum of sporadic breast cancer patients. Onkologie.
30:14–19. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li SY, Rong MN and Iacopetta B: DNA
hypermethylation in breast cancer and its association with
clinicopathological features. Cancer Lett. 237:272–280. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
23
|
Yang X, Yan L and Davidson NE: DNA
methylation in breast cancer. Endocr Relat Cancer. 8:115–127. 2001.
View Article : Google Scholar
|
|
24
|
Szyf M, Pakneshan P and Rabbani SA: DNA
methylation and breast cancer. Biochem Pharmacol. 68:1187–1197.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rocco JW and Sidransky D:
p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res.
264:42–55. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sherr CJ and McCormick F: The RB and p53
pathways in cancer. Cancer Cell. 2:103–112. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McDermott KM, Zhang JM, Holst CR,
Kozakiewicz BK, Singla V and Tlsty TD: p16(INK4a) prevents
centrosome dysfunction and genomic instability in primary cells.
PLoS Biol. 4:350–365. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bender CM, Pao MM and Jones PA: Inhibition
of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth
of human tumor cell lines. Cancer Res. 58:95–101. 1998.
|
|
29
|
Zhang B, Huang T, Liu K, Chen J and Wang
G: Effects of 5-Aza-CdR on cell proliferation of breast cancer cell
line MDA-MB-435S and expression of maspin gene. J Huazhong Univ of
Sci Technology Med Sci. 27:543–546. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
David GL, Yegnasubramanian S, Kumar A, et
al: MDR1 promoter hypermethylation in MCF7 human breast cancer
cells - Changes in chromatin structure induced by treatment with
5-aza-cytidine. Cancer Biol Ther. 3:540–548. 2004. View Article : Google Scholar : PubMed/NCBI
|
